Weight Loss
GLP-1 Use Doubles Across America — Here’s Who’s Taking Them
New Gallup data shows GLP-1 use has doubled nationwide as telehealth startups and investors are reshaping the weight-loss market.
ATN Week in Review: US Gyms Keep Winning, Raising Cash
This week, we break down more good news for America's big-box gyms, and look into the complexities surrounding the U.S.'s obesity crisis.
Why America’s Obesity Crisis Is Complicated
While obesity rates have fallen in some U.S. States, researchers warn that current definitions don't paint a full picture of America's weight crisis.
WeightWatchers, Amazon Team Up for Fast-Tracked Weight-Loss Meds
WeightWatchers has teamed with Amazon Pharmacy to simplify access to GLP-1 weight-loss drugs with real-time stock updates and home delivery.
America’s Obesity Crisis Is Much Worse Than You Think, Researchers Warn
Under a new definition of obesity endorsed by the The American Heart Association, 70% of Americans are obese, up from 40% currently.
Kevin Hart’s VC Firm Leads $35M Round for AI Weight Loss App
The AI-powered Simple Life app ditches calorie counting in favor of data-driven coaching, gamification and habit science.
Personal Trainers Say Their Jobs Are Changing Due to the Rise of GLP-1s
NASM's new survey of 500 fitness pros shows GLP-1 drugs like Ozempic are reshaping the industry and the role of personal trainers.
Wearables Uncover Hidden Insights Into Overeating in New Study
A necklace, wristband and bodycam helped researchers reveal five hidden overeating styles that could shape the future of obesity treatment.
Rebel Wilson, Noom Partner as GLP-1s Enter Microdose Era
Rebel Wilson joins Noom as chief wellness ambassador, backing its new free tier that gamifies healthy habits and spotlights microdose GLP-1s.
Apple Fitness+ Partners With GLP-1 Provider FuturHealth
FuturHealth, a provider of weight-loss solutions including GLP-1s, will offer Apple Fitness+ at no additional cost to its members.
